JY509 Universal NK Cell Injection

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JY509 Universal NK Cell Injection, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALL [EARLY_Phase 1]